BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17981747)

  • 1. Lysyl oxidase and endothelial dysfunction: mechanisms of lysyl oxidase down-regulation by pro-inflammatory cytokines.
    Alcudia JF; Martinez-Gonzalez J; Guadall A; Gonzalez-Diez M; Badimon L; Rodriguez C
    Front Biosci; 2008 Jan; 13():2721-7. PubMed ID: 17981747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
    Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
    Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysyl oxidase (LOX) down-regulation by TNFalpha: a new mechanism underlying TNFalpha-induced endothelial dysfunction.
    Rodríguez C; Alcudia JF; Martínez-González J; Raposo B; Navarro MA; Badimon L
    Atherosclerosis; 2008 Feb; 196(2):558-64. PubMed ID: 17673218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases.
    Rodríguez C; Martínez-González J; Raposo B; Alcudia JF; Guadall A; Badimon L
    Cardiovasc Res; 2008 Jul; 79(1):7-13. PubMed ID: 18469024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low density lipoproteins downregulate lysyl oxidase in vascular endothelial cells and the arterial wall.
    Rodríguez C; Raposo B; Martínez-González J; Casaní L; Badimon L
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1409-14. PubMed ID: 12231558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells.
    Raposo B; Rodríguez C; Martínez-González J; Badimon L
    Atherosclerosis; 2004 Nov; 177(1):1-8. PubMed ID: 15488859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of lysyl oxidase in venous malformations: Association with vascular destabilization and sclerotherapy.
    Zhu J; Shao M; Guo F; Ren J; Tang Z; Geng J; Xu Z; Jia J; Chen L; Jia Y
    J Dermatol; 2020 May; 47(5):518-526. PubMed ID: 32162383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Roles of Lysyl Oxidases in the Cardiovascular System: New Concepts and Therapeutic Challenges.
    Martínez-González J; Varona S; Cañes L; Galán M; Briones AM; Cachofeiro V; Rodríguez C
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31615160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of collagen deposition and lysyl oxidase by tumor necrosis factor-alpha in osteoblasts.
    Pischon N; Darbois LM; Palamakumbura AH; Kessler E; Trackman PC
    J Biol Chem; 2004 Jul; 279(29):30060-5. PubMed ID: 15138266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of collagen, lysyl oxidase and MMP-2 in human periodontal ligament cells by low- and high-level mechanical stretching.
    Chen YJ; Jeng JH; Chang HH; Huang MY; Tsai FF; Yao CC
    J Periodontal Res; 2013 Aug; 48(4):466-74. PubMed ID: 23190051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysyl oxidase as a potential therapeutic target.
    Rodríguez C; Rodríguez-Sinovas A; Martínez-González J
    Drug News Perspect; 2008 May; 21(4):218-24. PubMed ID: 18560621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysyl oxidase resolves inflammation by reducing monocyte chemoattractant protein-1 in abdominal aortic aneurysm.
    Onoda M; Yoshimura K; Aoki H; Ikeda Y; Morikage N; Furutani A; Matsuzaki M; Hamano K
    Atherosclerosis; 2010 Feb; 208(2):366-9. PubMed ID: 19683237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced ROS signaling is required for LOX up-regulation in endothelial cells.
    Guadall A; Orriols M; Alcudia JF; Cachofeiro V; Martinez-Gonzalez J; Rodriguez C
    Front Biosci (Elite Ed); 2011 Jun; 3(3):955-67. PubMed ID: 21622104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
    Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
    Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrostenotic eosinophilic esophagitis might reflect epithelial lysyl oxidase induction by fibroblast-derived TNF-α.
    Kasagi Y; Dods K; Wang JX; Chandramouleeswaran PM; Benitez AJ; Gambanga F; Kluger J; Ashorobi T; Gross J; Tobias JW; Klein-Szanto AJ; Spergel JM; Cianferoni A; Falk GW; Whelan KA; Nakagawa H; Muir AB
    J Allergy Clin Immunol; 2019 Jul; 144(1):171-182. PubMed ID: 30578874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel function for lysyl oxidase in pluripotent mesenchymal cell proliferation and relevance to inflammation-associated osteopenia.
    Khosravi R; Sodek KL; Xu WP; Bais MV; Saxena D; Faibish M; Trackman PC
    PLoS One; 2014; 9(6):e100669. PubMed ID: 24971753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-α induced down-regulation of lysyl oxidase family in anterior cruciate ligament and medial collateral ligament fibroblasts.
    Xie J; Jiang J; Huang W; Zhang Y; Xu C; Wang C; Yin L; Chen PC; Sung KL
    Knee; 2014 Jan; 21(1):47-53. PubMed ID: 23490076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats.
    Miana M; Galán M; Martínez-Martínez E; Varona S; Jurado-López R; Bausa-Miranda B; Antequera A; Luaces M; Martínez-González J; Rodríguez C; Cachofeiro V
    Dis Model Mech; 2015 Jun; 8(6):543-51. PubMed ID: 26035864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysyl Oxidase (LOX): Functional Contributions to Signaling Pathways.
    Laczko R; Csiszar K
    Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32708046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysyl oxidase overexpression accelerates cardiac remodeling and aggravates angiotensin II-induced hypertrophy.
    Galán M; Varona S; Guadall A; Orriols M; Navas M; Aguiló S; de Diego A; Navarro MA; García-Dorado D; Rodríguez-Sinovas A; Martínez-González J; Rodriguez C
    FASEB J; 2017 Sep; 31(9):3787-3799. PubMed ID: 28522596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.